If you missed the EMBL April 2021 Seminar, you can still listen to our keynote speaker Mathias Uhlén present on the topic of "The Human Protein Atlas – implications for human biology, drug development and precision medicine".
If you fill out the form you will receive access to the recorded presentation from Mathias Uhlén given during the seminar.
Simply type in your details and press Submit to get immediate access to the content.
Olink offers an unmatched high-multiplex technique to identify actionable biomarkers, with a strong focus on the human plasma proteome. Using minimal sample volume we provide quantifiable results with high-throughput, exceptional sensitivity and specificity, with coverage across a broad dynamic range. Our mission is to accelerate proteomics together with the scientific community across multiple disease areas to enable new discoveries and better understand complex real-time human biology. We are committed to develop our offering and are continuously expanding our protein coverage for a growing number of biological processes and pathways.
Olink is well-established in Europe (HQ Uppsala, Sweden) and the USA (HQ Boston, MA), with a rapidly developing presence across Asia. We also work with a growing number of core labs around the world offering analysis and support to an expanding global customer base.